Syndax to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 8, 2023

WALTHAM, Mass., May 1, 2023 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that... | May 1, 2023

Related Keywords

Sharon Klahre ,Nasdaq ,Syndax Pharmaceuticals ,Twitter ,Linkedin ,Prnewswire Syndax Pharmaceuticals Inc ,International Number ,Syndax Pharmaceuticals Inc ,Dial In Number ,Nc Stock Exchange ,News ,Information ,Press Release ,Bay ,023 ,Syndax ,Iopharmaceutical ,Company ,Developing ,N ,Nnovative ,Pipeline ,F ,Dancer ,Oday ,Nnounced Sndx Us87164f1057 ,